The trademark application PingPongParkinson was filed by Nenad Bach, a national of the United States of America (the "Applicant"). The application was published for oppositions on October 20, 2020, and it was registered by office on January 27, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021.
Goods And Services
The mark was filed in class 16 with following description of goods:
Stationery
Printed matter
Gift bags made of paper
Gift labels and tags
Posters
Stickers
Books
Magazines in the form of information and promotional for Parkinson's disease
Pictures
Prints
Paintings
Bookmarks
All of the aforementioned provided in the cover of the treatment of the halting of the progression of Parkinson's Disease.
The mark was filed in class 25 with following description of goods:
Clothing
Footwear
Headwear inter lia, sports caps and hats, headbands
Hats
Socks
Hoodies.
The mark was filed in class 26 with Clothing accessories including badges, pins, brooches.
The mark was filed in class 36 with following description of goods:
Organisation of fundraising activities and events for Parkinson's disease
Charitable fund raising and support services
Financial services relating to charities and fundraising.
The mark was filed in class 38 with following description of goods:
Broadcasting of Ping pong events
Advisory and consultancy services all relating to the aforesaid
All of the aforesaid services provided to sufferers of Parkinson's Disease in the context of the treatment of the halting the progression of Parkinson's Disease.
The mark was filed in class 41 with following description of goods:
Sporting services namely ping pong
Organisation of ping pong tournaments
Entertainment in the nature of ping pong tournaments
Staging of tournaments
Organising exercise classes
Advisory and consultancy services all relating to the aforesaid
All of the aforesaid services provided to sufferers of Parkinson's Disease in the context of the treatment of the halting the progression of Parkinson's Disease.